Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to $10.5 million.

  • Silo Pharma's Shares Outstanding rose 13307.58% to $10.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.5 million, marking a year-over-year increase of 13307.58%. This contributed to the annual value of $4.5 million for FY2024, which is 4195.38% up from last year.
  • As of Q3 2025, Silo Pharma's Shares Outstanding stood at $10.5 million, which was up 13307.58% from $8.7 million recorded in Q2 2025.
  • Over the past 5 years, Silo Pharma's Shares Outstanding peaked at $100.5 million during Q3 2022, and registered a low of $1.7 million during Q1 2021.
  • For the 5-year period, Silo Pharma's Shares Outstanding averaged around $19.1 million, with its median value being $3.2 million (2022).
  • As far as peak fluctuations go, Silo Pharma's Shares Outstanding tumbled by 9768.3% in 2021, and later surged by 573703.47% in 2022.
  • Quarter analysis of 5 years shows Silo Pharma's Shares Outstanding stood at $2.0 million in 2021, then skyrocketed by 60.14% to $3.2 million in 2022, then changed by 0.0% to $3.2 million in 2023, then surged by 41.95% to $4.5 million in 2024, then skyrocketed by 133.28% to $10.5 million in 2025.
  • Its last three reported values are $10.5 million in Q3 2025, $8.7 million for Q2 2025, and $4.5 million during Q1 2025.